Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'bisphosphonates' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 695 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sun, JS; Huang, YC; Tsuang, YH; Chen, LT; Lin, FH
      Sintered dicalcium pyrophosphate increases bone mass in ovariectomized rats

      JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
    2. Alvarez, L; Guanabens, N; Peris, P; Vidal, S; Ros, I; Monegal, A; Bedini, JL; Deulofeu, R; Pons, F; Munoz-Gomez, J; Ballesta, AM
      Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease

      BONE
    3. Mashiba, T; Turner, CH; Hirano, T; Forwood, MR; Jacob, DS; Johnston, CC; Burr, DB
      Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures

      BONE
    4. Ito, M; Amizuka, N; Nakajima, T; Ozawa, H
      Bisphosphonate acts on osteoclasts independent of ruffled borders in osteosclerotic (oc/oc) mice

      BONE
    5. Benford, HL; McGowan, NWA; Helfrich, MH; Nuttall, ME; Rogers, MJ
      Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro

      BONE
    6. Mansfield, K; Teixeira, CC; Adams, CS; Shapiro, IM
      Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism

      BONE
    7. Zegels, B; Eastell, R; Russell, RGG; Ethgen, D; Roumagnac, I; Collette, J; Reginster, JY
      Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis

      BONE
    8. Adachi, JD
      Corticosteroid-induced osteoporosis

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    9. Miller, PD
      New possibilities for diagnosis and treatment of osteoporosis

      INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
    10. Rosen, LS; Gordon, D; Kaminski, M; Howell, A; Belch, A; Mackey, J; Apffelstaedt, J; Hussein, M; Coleman, RE; Reitsma, DJ; Seaman, JJ; Chen, BL; Ambros, Y
      Zoledronic acid versus pamidronate in the treatment of skeletal metastasesin patients with breast cancer or osteolytic lesions of multiple myeloma: A phase III, double-blind, comparative trial

      CANCER JOURNAL
    11. Pande, I; Francis, RM
      Osteoporosis in men

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    12. Woo, T; Adachi, JD
      Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    13. Hamdy, FC; Thomas, BG
      New therapeutic concepts in prostate cancer

      BJU INTERNATIONAL
    14. Docampo, R
      Recent developments in the chemotherapy of Chagas' disease

      CURRENT PHARMACEUTICAL DESIGN
    15. Peters, JL; Fairney, A; Kyd, P; Patel, A; Rogers, S; Webster, JJ; Vale, JA; Witherow, RON
      Bone loss associated with the use of LHRH agonists in prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    16. Mishra, A; Wong, L; Jonklaas, J
      Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism

      ENDOCRINE
    17. Fleisch, H
      Bisphosphonates: mechanisms of action

      EXPERT OPINION ON THERAPEUTIC PATENTS
    18. Chevrel, G; Meunier, PJ
      Osteogenesis imperfecta: lifelong management is imperative and feasible

      JOINT BONE SPINE
    19. Matczak-Jon, E; Sawka-Dobrowolska, W; Kafarski, P; Videnova-Adrabinska, V
      Molecular organization and solution properties of N-substituted aminomethane-1,1-diphosphonic acids

      NEW JOURNAL OF CHEMISTRY
    20. Parisi, MS; Oliveri, MB; Acotto, CG; Mautalen, CA
      Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia

      JOURNAL OF CLINICAL DENSITOMETRY
    21. Price, PA; Faus, SA; Williamson, MK
      Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    22. Price, PA; June, HH; Buckley, JR; Williamson, MK
      Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    23. Maritz, FJ; Conradie, MM; Hulley, PA; Gopal, R; Hough, S
      Effect of statins on bone mineral density and bone histomorphometry in rodents

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    24. Davidson, TG
      Conventional treatment of hypercalcemia of malignancy

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    25. Berenson, JR
      Advances in the biology and treatment of myeloma bone disease

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    26. Papaioannou, A; Ferko, NC; Adachi, JD
      All patients with inflammatory bowel disease should have bone density assessment: Pro

      INFLAMMATORY BOWEL DISEASES
    27. Markowitz, GS; Appel, GB; Fine, PL; Fenves, AZ; Loon, NR; Jagannath, S; Kuhn, JA; Dratch, AD; D'Agati, VD
      Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    28. Pieper, T; Keppler, BK
      Quinolone antibacterial agents linked to osteotropic bisphosphonate moieties

      PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS
    29. Reale, C; Turkiewicz, AM; Reale, CA
      Antalgic treatment of pain associated with bone metastases

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    30. Pritchard, SC; Nicolson, MC; Lloret, C; McKay, JA; Ross, VG; Kerr, KM; Murray, GI; McLeod, HL
      Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: Implications for MMP inhibition therapy

      ONCOLOGY REPORTS
    31. de Murphy, CA; Ferro-Flores, G; Pedraza-Lopez, M; Melendez-Alafort, L; Croft, BY; Ramirez, FD; Padilla, J
      Labelling of Re-ABP with Re-188 for bone pain palliation

      APPLIED RADIATION AND ISOTOPES
    32. Sen, D; Keen, RW
      Osteoporosis in systemic lupus erythematosus: prevention and treatment

      LUPUS
    33. Vincent, SP; Grenier, S; Mioskowski, C; Salesse, C; Lebeau, L
      Probing the transducin nucleotide binding site with GDP analogues

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    34. Szajnman, SH; Bailey, BN; Docampo, R; Rodriguez, JB
      Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    35. des Grottes, JM; Dumon, JC; Body, JJ
      Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonates

      MELANOMA RESEARCH
    36. Smith, R
      Severe osteogenesis imperfecta: new therapeutic options? Aminobisphosphonates offer promise, while bone marrow transplants remain experimental

      BRITISH MEDICAL JOURNAL
    37. Perez, M; Migliaccio, S; Taranta, A; Festuccia, C; Orru, L; Brama, M; Bologna, M; Faraggiana, T; Baron, R; Teti, A
      Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines

      EUROPEAN JOURNAL OF CANCER
    38. Sonnemann, J; Eckervogt, V; Truckenbrod, B; Boos, J; Winkelmann, W; van Valen, F
      The bisphosphonate pamidronate is a potent inhibitor of human osteosarcomacell growth in vitro

      ANTI-CANCER DRUGS
    39. Huk, OL; Zukor, DJ; Ralston, W; Lisbona, A; Petit, A
      Apoptosis in interface membranes of aseptically loose total hip arthroplasty

      JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
    40. Lamy, O; Jenzer-Closuit, A; Burckhardt, P
      Hypercalcaemia of malignancy: an undiagnosed and undertreated disease

      JOURNAL OF INTERNAL MEDICINE
    41. Beusterien, KM; Hill, MC; Ackerman, SJ; Zacker, C
      The impact of pamidronate on inpatient and outpatient services among metastatic breast cancer patients

      SUPPORTIVE CARE IN CANCER
    42. Varenna, M; Binelli, L; Zucchi, F; Ghiringhelli, D; Sinigaglia, L
      Unbalanced diet to lower serum cholesterol level is a risk factor for postmenopausal osteoporosis and distal forearm fracture

      OSTEOPOROSIS INTERNATIONAL
    43. Reginster, JY; Christiansen, C; Roux, C; Fechtenbaum, J; Rouillon, A; Tou, KP
      Intermittent cyclic tiludronate in the treatment of osteoporosis

      OSTEOPOROSIS INTERNATIONAL
    44. Krieg, MA; Seydoux, C; Sandini, L; Goy, JJ; Berguer, DG; Thiebaud, D; Burckhardt, P
      Intravenous pamidronate as treatment for osteoporosis after heart transplantation: A prospective study

      OSTEOPOROSIS INTERNATIONAL
    45. Cranney, A; Guyatt, G; Krolicki, N; Welch, V; Griffith, L; Adachi, JD; Shea, B; Tugwell, P; Wells, G
      A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis

      OSTEOPOROSIS INTERNATIONAL
    46. Bayne, MC; Illidge, TM
      Hypercalcaemia, parathyroid hormone-related protein and malignancy

      CLINICAL ONCOLOGY
    47. Jagdev, SP; Purohit, OP; Heatley, S; Herling, C; Coleman, RE
      Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease

      ANNALS OF ONCOLOGY
    48. Ikai, T; Uematsu, M; Eun, SS; Kimura, C; Hasegawa, C; Miyano, S
      Prevention of secondary osteoporosis postmenopause in hemiplegia

      AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
    49. Noxon, SJ; King, GJ; Gu, GM; Huang, G
      Osteoclast clearance from periodontal tissues during orthodontic tooth movement

      AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS
    50. Walsh, JME; Wheat, ME; Freund, KM
      Untitled - Reply

      JOURNAL OF GENERAL INTERNAL MEDICINE
    51. Stuckey, BGA; Lim, EM; Kent, GN; Ward, LC; Gutteridge, DH
      Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: Profound hypocalcemia, rapid response, and prolonged remission

      JOURNAL OF BONE AND MINERAL RESEARCH
    52. Mathov, I; Plotkin, LI; Sgarlata, CL; Leoni, J; Bellido, T
      Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro

      JOURNAL OF BONE AND MINERAL RESEARCH
    53. Riis, BJ; Ise, J; Von Stein, T; Bagger, Y; Christiansen, C
      Ibandronate: A comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis

      JOURNAL OF BONE AND MINERAL RESEARCH
    54. Rossini, M; Gatti, D; Isaia, G; Sartori, L; Braga, V; Adami, S
      Effects of oral alendronate in elderly patients with osteoporosis and mildprimary hyperparathyroidism

      JOURNAL OF BONE AND MINERAL RESEARCH
    55. Go, T
      Low-dose oral etidronate therapy for immobilization hypercalcaemia associated with Guillain-Barre syndrome

      ACTA PAEDIATRICA
    56. Major, P; Lortholary, A; Hon, J; Abdi, E; Mills, G; Menssen, HD; Yunus, F; Bell, R; Body, J; Quebe-Fehling, E; Seaman, J
      Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials

      JOURNAL OF CLINICAL ONCOLOGY
    57. Saarto, T; Blomqvist, C; Virkkunen, P; Elomaa, I
      Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial

      JOURNAL OF CLINICAL ONCOLOGY
    58. Quattrocchi, O; Frisardi, L; Iglesias, M; Noya, M; Caputto, M; Ferraris, D; Siliprandi, D; Piccinni, E
      Ion exchange chromatographic determination of olpadronate, phosphate, phosphite, chloride and methanesulfonic acid

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    59. Heaney, RP
      Constructive interactions among nutrients and bone-active pharmacologic agents with principal emphasis on calcium, phosphorus, vitamin D and protein

      JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
    60. Monkkonen, H; Rogers, MJ; Makkonen, M; Niva, S; Auriola, S; Monkkonen, J
      The cellular uptake and metabolism of clodronate in RAW 264 macrophages

      PHARMACEUTICAL RESEARCH
    61. Guo, Y; Chen, QY
      The electron transfer reactions of 1, 3-diiodohexafluoropropane

      ACTA CHIMICA SINICA
    62. Van Offel, JF; Schuerwegh, AJ; Bridts, CH; Bracke, PG; Stevens, WJ; De Clerck, LS
      Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    63. Tjalma, WA; Buytaert, PM; Berneman, ZN
      Reduction of visible bone metastases by clodronate therapy in breast cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    64. Genvresse, I; Wedding, U; Bokemeyer, C; Spath-Schwalbe, E
      Treatment of multiple myeloma in the elderly: Consensus of the cooperativegroup of geriatric oncology of the DGHO and DGG

      ONKOLOGIE
    65. Raiman, J; Niemi, R; Vepsalainen, J; Yritys, K; Jarvinen, T; Monkkonen, J
      Effects of calcium and lipophilicity on transport of clodronate and its esters through Caco-2 cells

      INTERNATIONAL JOURNAL OF PHARMACEUTICS

    66. Zoledronic acid monohydrate - CGP-42446 - Zometa (R) - Treatment of hypercalcemia

      DRUGS OF THE FUTURE
    67. Huuskonen, J; Arnala, I; Olkkonen, H; Alhava, E
      Alendronate influences bending force of femoral diaphysis after orchidectomy in rats

      ANNALES CHIRURGIAE ET GYNAECOLOGIAE
    68. Huuskonen, J; Arnala, I; Olkkonen, H; Alhava, E
      Pamidronate increases trabecular bone mineral density in immobilization osteopenia in male rats

      ANNALES CHIRURGIAE ET GYNAECOLOGIAE
    69. Bonabello, A; Galmozzi, MR; Bruzzese, T; Zara, GP
      Analgesic effect of bisphosphonates in mice

      PAIN
    70. Tomiska, M; Adam, Z; Prokes, B; Dusek, L; Hajek, R; Vorlicek, J
      Bone mineral density in multiple myeloma patients after intravenous clodronate therapy

      ACTA MEDICA AUSTRIACA
    71. Little, DG; Cornell, MS; Briody, J; Cowell, CT; Arbuckle, S; Cooke-Yarborough, CM
      Intravenous pamidronate reduces osteoporosis and improves formation of theregenerate during distraction osteogenesis - A study in immature rabbits

      JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
    72. Cruz, JC; Alsina, M; Craig, F; Yoneda, T; Anderson, JL; Dallas, M; Roodman, GD
      Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma

      EXPERIMENTAL HEMATOLOGY
    73. Schmid, I; Stachel, D; Schon, C; Bauer, M; Haas, RJ
      Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children

      KLINISCHE PADIATRIE
    74. Takaishi, Y; Miki, T; Nishizawa, Y; Morii, H
      Clinical effect of etidronate on alveolar pyorrhoea associated with chronic marginal periodontitis: Report of four cases

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    75. Groff, L; Zecca, E; De Conno, F; Brunelli, C; Boffi, R; Panzeri, C; Cazzaniga, M; Ripamonti, C
      The role of disodium pamidronate in the management of bone pain due to malignancy

      PALLIATIVE MEDICINE
    76. Johnson, IS
      Use of bisphosphonates for the treatment of metastatic bone pain. A surveyof palliative physicians in the UK

      PALLIATIVE MEDICINE
    77. Gnudi, S; Lisi, L; Fini, M; Malavolta, N
      Effect of intramuscular clodronate on bone mass and metabolism in osteoporotic women

      INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS
    78. Lortholary, A
      Tumor-induced hypercalcemia. A review of the treatment by bisphosphonates

      REVUE DE MEDECINE INTERNE
    79. Hokelek, T; Bilge, S; Akduran, N; Kilic, Z
      Crystal structure of 15,21-bis(diethoxyphosphinoyl)-2,5,8-trioxa-16,20-diazatricyclo-[20.4.0.0(9,14)] hexacosa-9,11,13,22,24,26(1)-hexaene-ethylphosphonic acid-water (1/1/1)

      CRYSTAL RESEARCH AND TECHNOLOGY
    80. Yilmaz, L; Ozoran, K; Gunduz, OH; Ucan, H; Yucel, M
      Alendronate in rheumatoid arthritis patients treated with methotrexate andglucocorticoids

      RHEUMATOLOGY INTERNATIONAL
    81. Adami, S; Prizzi, R; Colapietro, F
      Alendronate for the treatment of osteoporosis in men

      CALCIFIED TISSUE INTERNATIONAL
    82. Edwards, CJ; Russell, RGG; Spector, TD
      Statins and bone: Myth or reality?

      CALCIFIED TISSUE INTERNATIONAL
    83. Camacho, NP; Raggio, CL; Doty, SB; Root, L; Zraick, V; Ilg, WA; Toledano, TR; Boskey, AL
      A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta

      CALCIFIED TISSUE INTERNATIONAL
    84. Terpos, E; Palermos, J; Viniou, N; Vaiopoulos, G; Meletis, J; Yataganas, X
      Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment

      CALCIFIED TISSUE INTERNATIONAL
    85. Hyldstrup, L; Jorgensen, JT; Sorensen, TK; Baeksgaard, L
      Response of cortical bone to antiresorptive treatment

      CALCIFIED TISSUE INTERNATIONAL
    86. Zeevaart, JR; Jarvis, NV; Louw, WKA; Jackson, GE
      Metal-ion speciation in blood plasma incorporating the tetraphosphonate, N,N-dimethylenephosphonate-1-hydroxy-4-aminopropilydenediphosphonate (APDDMP), in therapeutic radiopharmaceuticals

      JOURNAL OF INORGANIC BIOCHEMISTRY
    87. Umland, EM; Boyce, EG
      Risedronate: A new oral bisphosphonate

      CLINICAL THERAPEUTICS
    88. Drake, WM; Kendler, DL; Brown, JP
      Consensus statement on the modern therapy of Paget's disease of bone from a western osteoporosis alliance symposium

      CLINICAL THERAPEUTICS
    89. Reid, IR; Hague, W; Emberson, J; Baker, J; Tonkin, A; Hunt, D; MacMahon, S; Sharpe, N
      Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial

      LANCET
    90. da Paz, LHBC; de Falco, V; Teng, NC; dos Reis, LM; Pereira, RMR; Jorgetti, V
      Effect of 17 beta-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized rats

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    91. Brown, RE
      Bisphosphonates as antialveolar macrophage therapy in pulmonary Langerhanscell histiocytosis?

      MEDICAL AND PEDIATRIC ONCOLOGY
    92. Janjan, N
      Bone metastases: Approaches to management

      SEMINARS IN ONCOLOGY
    93. Perez, EA
      Metastatic bone disease in breast cancer: The patient's perspective

      SEMINARS IN ONCOLOGY
    94. Berenson, JR
      Zoledronic acid in cancer patients with bone metastases: Results of phase I and II trials

      SEMINARS IN ONCOLOGY
    95. Fleisch, H
      Zoledronic acid: An evolving role in the treatment of cancer patients withbone disease

      SEMINARS IN ONCOLOGY
    96. Ringe, JD
      Fluorides and bisphosphonates in the treatment of osteoporosis

      ORTHOPADE
    97. Haworth, CS; Selby, PL; Adams, JE; Mawer, EB; Horrocks, AW; Webb, AK
      Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis

      THORAX
    98. Lecouvey, M; Mallard, I; Burgada, R; Leroux, Y
      A mild and efficient one-pot synthesis of 1-hydroxymethylene-1,1-bisphosphonic acids. Preparation of new tripod ligands

      TETRAHEDRON LETTERS
    99. Page, PCB; Moore, JPG; Mansfield, I; McKenzie, MJ; Bowler, WB; Gallagher, JA
      Synthesis of bone-targeted oestrogenic compounds for the inhibition of bone resorption

      TETRAHEDRON
    100. Steinmeyer, A; Schwarz, K; Haberey, M; Langer, G; Wiesinger, H
      Synthesis and biological activities of a new series of secosteroids: vitamin D phosphonate hybrids

      STEROIDS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 16:05:47